샘플 요청 목록

 카트 문의
시장보고서
상품코드
1563890

연속혈당측정시스템 시장

Continuous Glucose Monitoring Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 202 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

연속혈당측정시스템 시장은 2030년까지 103억 달러에 도달할 전망입니다.

2023년에 36억 달러로 추정된 연속혈당측정시스템 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 15.9%로 성장하고 2030년에는 103억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 센서 컴포넌트는 복합 연간 성장률(CAGR) 14.7%로 성장을 지속하고, 분석 기간 종료 시 54억 달러에 이를 것으로 예상됩니다. 송신기 및 수신기 컴포넌트 부문은 분석 기간 동안 복합 연간 성장률(CAGR) 16.8%의 성장이 예상됩니다.

미국 시장은 추정 9억 6,510만 달러, 중국은 복합 연간 성장률(CAGR) 22.5%로 성장할 것으로 예측됩니다.

미국의 연속혈당측정시스템 시장은 2023년 9억 6,510만 달러로 추정됐습니다. 세계의 2위 경제대국인 중국은 2030년까지 28억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR)은 22.5%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 각각 분석 기간 중에 12.2%와 13.0%의 복합 연간 성장률(CAGR)로 성장할 것으로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 12.3%로 성장할 것으로 예측됩니다.

세계의 지속 포도당, 모니터링 및 시스템 시장 - 주요 동향과 촉진요인 요약

연속혈당측정시스템은 당뇨병 관리에 어떤 혁명을 가져왔는가?

지속적인 포도당 모니터링(CGM) 시스템은 포도당 수준에 대한 실시간 인사이트을 제공함으로써 당뇨병 관리에 혁명을 일으켜 더 나은 혈당 조절과 더 많은 정보를 바탕으로 치료 정책을 결정할 수 있습니다. 기존의 손가락을 찌르는 방법과 달리 CGM 장치는 피하에 삽입된 센서로 포도당 수준을 지속적으로 측정하여 스마트폰과 전용 리더에서 액세스할 수 있는 데이터를 제공합니다. 이 기술적 진보는 혈당 수준의 패턴과 동향을 추적하는 능력을 크게 향상시켜 환자와 건강 관리 제공업체가 치료 계획을 보다 효과적으로 조정할 수 있게 합니다. CGM 시스템이 제공하는 편의성과 정확성은 정확한 인슐린 투여가 필요한 1형 당뇨병 환자에게 특히 중요합니다. 게다가 인구 고령화, 앉기 쉬운 라이프스타일, 비만률 상승 등의 요인에 의해 세계의적으로 당뇨병의 유병률이 증가하고 있기 때문에 이러한 고급 모니터링 시스템 수요가 높아지고 있습니다.

CGM 디바이스의 미래를 형성하는 기술 혁신이란?

연속혈당측정시스템 시장은 장치의 정확성, 사용자 경험 및 데이터 분석 능력을 향상시키는 여러 기술 혁신에 의해 추진되고 있습니다. 장착 시간이 길고 캘리브레이션 횟수가 적은 보다 작고 편안한 센서의 개발로 환자의 충격과 만족도가 크게 향상되었습니다. 차세대 CGM 시스템은 인슐린 펌프와 통합되어 실시간 포도당 측정을 기반으로 인슐린 투여를 자동화하는 폐쇄 루프 시스템 또는 "인공 췌장" 설정을 구축합니다. 블루투스 기술과 스마트폰 앱 통합의 발전으로 사용자는 포도당 데이터를 간병인 및 건강 관리 제공업체와 쉽게 공유할 수 있어 보다 나은 당뇨병 관리가 촉진됩니다. 또한 잠재적인 포도당 수치의 동향을 예측하고 고혈당과 저혈당을 예방하기 위한 경보를 제공하기 위해 예측 분석과 AI 기반 알고리즘이 채택되었습니다. 이러한 기술적 진보는 CGM 시스템의 효능을 높일 뿐만 아니라 당뇨병 관리를 보다 적극적이고 개별화한 것으로 하고 있습니다.

규제 당국의 승인과 상환 정책은 CGM 시장에 어떤 영향을 미치는가?

규제 당국의 승인과 유리한 상환 정책은 연속혈당측정시스템 시장의 확대를 촉진하는 중요한 요소입니다. 최근 미국 식품의약국(FDA)과 유럽의약청(EMA)과 같은 규제기관은 환자의 결과를 개선하고 건강 관리 비용을 절감할 가능성을 인식하고 새로운 CGM 장치 승인을 신속하게 진행 있습니다. 이러한 규제 당국의 승인은 CGM 시스템의 안전성과 효능에 대한 건강 관리 제공업체와 환자의 신뢰를 높이고 있습니다. 또한 일부 국가의 보험회사와 정부의 건강 관리 프로그램은 CGM 장비의 적용 범위를 확대하고 있으며 당뇨병 인구의 더 많은 층이 CGM 장비에 접근할 수 있게 되었습니다. CGM시스템의 의료보험 상환 계획에의 임베디드이 증가하고 있는 것은 특히 상시 감시를 필요로 하는 노인이나 1형 당뇨병 환자 사이에서 보다 광범위한 채용과 사용을 가능하게 하는 중요한 요인과 되어 있습니다.

지속 포도당,감시,시스템 시장의 성장을 가속하는 요인은?

연속혈당측정시스템 시장의 성장은 당뇨병 유병률 증가, 기술 진보, 지원 규제 및 상환 프레임 워크 등 여러 요인에 의해 견인되고 있습니다. 주요 촉진요인 중 하나는 더 나은 혈당 조절을 달성하기 위해 실시간 포도당 모니터링의 이점에 대한 환자와 건강 관리 제공업체의 의식 증가입니다. 또한, CGM 시스템의 보급은 디지털 헬스 플랫폼이나 모바일 애플리케이션과의 통합에 의해 촉진되고 있어, 유저 인게이지먼트의 향상이나 데이터 중심의 인사이트이 제공되고 있습니다. 게다가, 의료 산업에서 가치 기반 케어로의 전환은 당뇨병 관련 합병증과 전반적인 의료비를 절감하는 수단으로 CGM 시스템의 사용을 촉진하고 있습니다. 또한 CGM 장비 제조업체와 디지털 건강 기업 간의 전략적 제휴가 시장을 견인하고 있으며 데이터 분석과 인공지능을 통해 이러한 장비의 기능을 확장하고 있습니다. 이러한 요인은 종합적으로 세계의 CGM 시장의 견조한 성장 전망에 기여하고 있습니다.

조사 대상 기업 예(주목의 53사)

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.08

Global Continuous Glucose Monitoring Systems Market to Reach US$10.3 Billion by 2030

The global market for Continuous Glucose Monitoring Systems estimated at US$3.6 Billion in the year 2023, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Transmitters & Receivers Component segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.1 Million While China is Forecast to Grow at 22.5% CAGR

The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$965.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 22.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Continuous Glucose Monitoring Systems Market - Key Trends & Drivers Summarized

How Are Continuous Glucose Monitoring Systems Revolutionizing Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are revolutionizing the management of diabetes by providing real-time insights into glucose levels, allowing for better glycemic control and more informed treatment decisions. Unlike traditional finger-prick methods, CGM devices continuously measure glucose levels through a sensor inserted under the skin, offering data that can be accessed via smartphones or dedicated readers. This technological advancement significantly enhances the ability to track blood glucose patterns and trends, enabling patients and healthcare providers to tailor treatment plans more effectively. The convenience and accuracy provided by CGM systems are especially crucial for patients with Type 1 diabetes, who require precise insulin dosing. Furthermore, the increasing prevalence of diabetes globally, driven by factors such as aging populations, sedentary lifestyles, and rising obesity rates, is amplifying the demand for these advanced monitoring systems.

What Technological Innovations Are Shaping The Future Of CGM Devices?

The Continuous Glucose Monitoring systems market is being propelled by several technological innovations that are enhancing device accuracy, user experience, and data analytics capabilities. The development of smaller, more comfortable sensors that provide longer wear times and require fewer calibrations is significantly improving patient adherence and satisfaction. Next-generation CGM systems are integrating with insulin pumps, creating closed-loop systems or “artificial pancreas” setups that automate insulin delivery based on real-time glucose readings. Advances in Bluetooth technology and smartphone app integrations are allowing users to easily share their glucose data with caregivers and healthcare providers, promoting better diabetes management. Furthermore, predictive analytics and AI-based algorithms are being employed to forecast potential glucose level trends, providing alerts to prevent hyperglycemia or hypoglycemia. These technological advancements are not only enhancing the effectiveness of CGM systems but are also making diabetes management more proactive and personalized.

How Are Regulatory Approvals And Reimbursement Policies Impacting The CGM Market?

Regulatory approvals and favorable reimbursement policies are crucial factors driving the expansion of the Continuous Glucose Monitoring systems market. In recent years, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-tracked approvals for new CGM devices, recognizing their potential to improve patient outcomes and reduce healthcare costs. These regulatory endorsements have instilled greater confidence among healthcare providers and patients regarding the safety and efficacy of CGM systems. Additionally, insurance companies and government healthcare programs in several countries are expanding their coverage for CGM devices, making them more accessible to a larger segment of the diabetic population. The increasing inclusion of CGM systems in health insurance reimbursement plans is a key factor enabling broader adoption and use, particularly among the elderly and those with Type 1 diabetes who require constant monitoring.

What Factors Are Driving The Growth Of The Continuous Glucose Monitoring Systems Market?

The growth in the Continuous Glucose Monitoring systems market is driven by several factors, including rising diabetes prevalence, technological advancements, and supportive regulatory and reimbursement frameworks. One of the key drivers is the increasing awareness among patients and healthcare providers about the benefits of real-time glucose monitoring for achieving better glycemic control. The growing adoption of CGM systems is also being fueled by their integration with digital health platforms and mobile applications, which offer enhanced user engagement and data-driven insights. Additionally, the shift toward value-based care in the healthcare industry is promoting the use of CGM systems as a means to reduce diabetes-related complications and overall healthcare costs. Further driving the market are strategic partnerships between CGM device manufacturers and digital health companies, which are expanding the capabilities of these devices through data analytics and artificial intelligence. These factors collectively contribute to the robust growth outlook for the CGM market worldwide.

Select Competitors (Total 53 Featured) -

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Diabetes and Need for Continuous Monitoring
    • Technological Advancements in CGM Device Accuracy and Connectivity
    • Rising Adoption of Wearable Health Monitoring Devices
    • Growing Demand for Non-Invasive Glucose Monitoring Solutions
    • Integration of CGM with Digital Health Platforms and Apps
    • Development of AI-Based Predictive Analysis in Diabetes Management
    • Increasing Awareness and Adoption Among Non-Diabetic Users
    • Expanding Availability of CGM Devices in Emerging Markets
    • Government Reimbursement Policies Supporting CGM Adoption
    • Innovations in Miniaturized and Implantable Glucose Sensors
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Continuous Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transmitters & Receivers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Integrated Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • INDIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AFRICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제